| Arnold, Jonathan (Qiagen 201606 Oncology Franchise Leader) |
Product Manager (personnel) |
Qiagen (Group) |
Netherlands |
| Arnold, Katja (MC Services 201309 CIRO Executive Director before Wilex AG + CAT Consultants) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Arnold, Lauren (MacDougall Biomedical Communications 201801) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Arnold, Matthias (DASGIP AG 201201 CEO) |
Board member, executive |
Eppendorf (Group) |
Germany |
| Arnot, Christopher (Merck (DE) 202209 Director BusDev + Licensing Gene Editing + Novel Modalities at Sigma-Aldrich) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
United States (USA) |
| Aron, Julien (Peak Scientific 201304– Territory Manager for France, Spain, Italy + Portugal) |
Regional manager |
Peak Scientific (Group) |
United Kingdom (GB) |
| Arth, Hans-Lothar (ABK Patent and Trademark Attorneys before Axxima) |
Patent Attorney |
ABK Patent, Trademark and Design Attorneys (Berlin) |
Germany |
| Artuso, Anthony (Merck (DE) 201310 VP Strategy + Business Development at EMD Millipore) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
United States (USA) |
| Asadi, Narges Bani (Bina Technologies 201412 CEO + Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Asadullah, Khusru (Bayer 200906 Head Target Discovery) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Asali, Omar (Ranpak 202110 CEO) |
Chief Executive Officer (CEO) |
Ranpak (US) |
United States (USA) |
| Asam, Alexander (HBM Partners 201304 Investment Advisor before Kaneas Capital 2006– founder before DVC) |
Investment Manager |
HBM (Group) |
Switzerland |
| Asam, Dominik (Infineon Technologies 200501) |
n. a. |
Infineon (Group) |
Germany |
| Asano, Marie (European Circular Bioeconomy Fund 202111 Princiap before HTGF 201902 Investment Manager) |
Principal (venture capital) |
ECBF (European Circular Bioeconomy Fund) (Group) |
Germany |
| Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) |
President/Director/Head Business Group/Unit/Division |
Otsuka (Group) |
United States (USA) |
| Ash, Nicholas Watson (Nick) (Source Bioscience 200812 Managing Director) |
Managing Director |
Source BioScience (Group) |
United Kingdom (GB) |
| Ashton, Mark (Evotec 200910 EVP Business Development) |
Business Development Manager / Strategy Manager |
Evotec (Group) |
Germany |
| Ashton, Paul (Inflammasome Therapeutics 201909 CEO) |
Chief Executive Officer (CEO) |
Inflammasome Therapeutics (US) |
United States (USA) |
| Asokan, Aravind (Univ of North Carolina at Chapel Hill 201704 + StrideBio Co-Founder) |
Researcher (university / research institute) |
University of North Carolina |
United States (USA) |
| Aspinall, Mara G. (Roche 201109– President Ventana Medical before On-Q-ity founder + CEO before Genzyme) |
President/Director/Head Business Group/Unit/Division |
LabCorp (Group) |
United States (USA) |
| Atkins, David (Congenica 201801– CEO before Synevo + Leica Biosystems + JnJ/Ortho Clinical Diagnostics) |
Chief Executive Officer (CEO) |
Congenica (Group) |
United Kingdom (GB) |
| Atkinson, Blair (MacDougall Biomedical Communications 201504) |
Public Relations Manager / Investor Relations Manager |
MacDougall Biomedical Communications Inc. (MBI) |
Germany |
| Atlas, Roee (Lonza 201710– Manager of Collaborative Innovation Center in Israel) |
management (personnel) |
Lonza (Group) |
Israel |
| Atrzadeh, Faranak (Curetis 201904 SVP Scientific Affairs + Marketing) |
Sales Manager / Marketing Manager |
OpGen (Group) |
Netherlands |
| Attinger, Per-Olof (Roche 199201– Head of Coporate Communication) |
communication policy |
Roche (Group) |
Switzerland |
| Audoly, Laurent (Parthenon Therapeutics 201909– CEO + Co-Founder before Kymera Therapeutics + Pierre Fabre + Pieris) |
Chief Executive Officer (CEO) |
Parthenon Therapeutics (US) |
United States (USA) |
| Auerbach, Günter (Bene-Arzneimittel GmbH 201307– Managing Director before Antisense Pharma + Bayer AG) |
Managing Director |
Bene-Arzneimittel GmbH |
Germany |
| Auf der Maur, Greta (AKos GmbH 201102 Managing Director) |
Managing Director |
AKos Consulting & Solutions Deutschland GmbH (AKos GmbH) |
Germany |
| Aufderheide, Michaela (Cultex Laboratories GmbH 201105 Managing Director + co-founder) |
Managing Director |
Cultex Laboratories GmbH |
Germany |
| Augé, Pascale (INSERM 201403– CEO of Inserm Transfert before Institut Pasteur + Neurotech + Entomed + AB Science) |
Chief Executive Officer (CEO) |
France (govt) |
France |
| Augello, Frank A. |
n. a. |
Qiagen (Group) |
Switzerland |
| Augerson, Sean (Qiagen 201404 VP Supply Chain – Strategic Partner Management) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
Germany |
| Augsburger, Marc (CURML-UTCF 201005 Operational Manager) |
n. a. |
University of Lausanne (UNIL) |
Switzerland |
| Augustin, Jens (Fraunhofer 201210 Head of Press + Public Affairs Fraunhofer IZI) |
n. a. |
Fraunhofer (Group) |
Germany |
| Augustin, Marc (PolyPeptide 2024Q1– CFO before Lonza + Smith & Nephew Orthopaedics + Alcoa Extrusion + Thyssen Krupp) |
Chief Financial Officer (CFO) |
PolyPeptide (Group) |
Switzerland |
| Aurentz, Vincent (Merck Serono 200809– Executive VP Portfolio Managem + Business Developm) |
Business Development Manager / Strategy Manager |
Merck (DE) (Group) |
Germany |
| Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) |
Principal (venture capital) |
Illumina (Group) |
United States (USA) |
| Avagyan, Lilit (Knauer 202012 Business Development Manager) |
Business Development Manager / Strategy Manager |
Knauer (Group) |
Germany |
| Avenard, Gilles (Acticor Biotech 201612 CEO) |
Chief Executive Officer (CEO) |
Acticor Biotech (Group) |
France |
| Avery, Michelle (MacDougall Biomedical Communications 201504) |
Public Relations Manager / Investor Relations Manager |
MacDougall Advisors Inc. |
United States (USA) |
| Awada, A. (Institut Jules Bordet 201105 Investigator) |
Researcher (university / research institute) |
Institut Jules Bordet |
Belgium |
| Awenius, Marc (VDI 202303 Head of Office of Bioökonomierat at VDI Technologiezentrum) |
n. a. |
VDI (Verein Deutscher Ingenieure e. V.) |
Germany |
| Ax, Oliver (ACD/Labs 200909– Account Manager Advanced Chemistry Development Germany GmbH) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
Germany |
| Axelson, Dodi (Danaher 202210 Head of Communciations at Cytiva) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
United Kingdom (GB) |
| Axon, Steven (Steve) (Glycomine 202207– CEO before Prothelia + Apellis Pharmaceuticals + Merck KGaA) |
Chief Executive Officer (CEO) |
Glycomine Inc. |
United States (USA) |
| Aygen, Sitke (INFAI GmbH 201309 Managing Director) |
Managing Director |
INFAI Institut für biomedizinische Analytic und NMR Imaging GmbH |
Germany |
| Aygün, Hüseyin (BioSpring GmbH 201205 Managing Director) |
Managing Director |
BioSpring (Group) |
Germany |
| Ayyoubi, Silvia (Roche 200803–201603 Head of Global Human Resources + Member of Corp Executive Committe RETIRED 3/16) |
Human Resources Manager |
Roche (Group) |
Switzerland |
| Azam, Usman (Oz) (Tmunity Therapeutics 201612– CEO before Novartis + Novaccel + Aspreva + JnJ) |
Chief Executive Officer (CEO) |
Gilead Sciences (Group) |
United States (USA) |
| Aziz, Kabeer (Adjuvant Capital 202105) |
Investment Manager |
Adjuvant Capital LLC |
United States (USA) |
| Azoulay, Sam (Roivant 201910 CMO at Roivant Pharma) |
Chief Medical Officer (CMO) |
Roivant (Group) |
Switzerland |
| Azzaoui, Kamal (Saverna Therapeutics 2017– CEO + Co-Founder before Novartis) |
Chief Executive Officer (CEO) |
Saverna Therapeutics AG |
Switzerland |
| Baag, Rima |
n. a. |
Genedata (Group) |
Switzerland |
| Baare, Johanna (Traceless Materials 202309 COO + Co-Founder) |
Chief Operating Officer (COO) |
Traceless Materials GmbH |
Germany |
| Baars, Jan (Dolosys GmbH 201305 Managing Director) |
Managing Director |
Dolosys GmbH |
Germany |
| Baaske, Philipp (NanoTemper 201410 Managing Director + Co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Baatz, Martin (Definiens 201104 VP Marketing) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
Germany |
| Babbush, Ryan (Alphabet 202101 Head of Quantum Algorithms at Google Quantum AI) |
n. a. |
Alphabet (formerly Google) (Group) |
United States (USA) |
| Babe, Greg (Bayer Corp 200807– CEO before CEO Bayer MaterialScience) |
Chief Executive Officer (CEO) |
Bayer (Group) |
United States (USA) |
| Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome) |
Chief Executive Officer (CEO) |
Gotham Therapeutics (Group) |
United States (USA) |
| Bach, Alfred (Axaron/Sygnis 200511–201010 CEO resigned 10/10 before BASF + Genentech) |
Chief Executive Officer (CEO) |
2invest (Group) |
Germany |
| Bach, Dani (+ND Capital 202105 Partner formerly Aravis + Index Ventures) |
Managing Partner (investment firm) |
+ND Capital (f.k.a. NanoDimension) |
Switzerland |
| Bach, Juri (High-Tech Gründerfonds 202001 Investment Manager) |
Investment Manager |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Bach, Susanne (Eucodis Bioscience GmbH 201604 Key Account Manager) |
Sales Manager / Marketing Manager |
Marinomed Biotech AG (VSE: MARI) |
Austria |
| Bache, Nicolai (Evosep 201803 Head of Applications) |
Technical Manager |
Evosep ApS |
Denmark |
| Bachelot-Fontaine, Laetitia (Valneva 201404 Investor Relations + Communications Manager) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
France |
| Bacher, Johannes (Curetis 201804 COO before Managing Director + Co-Founder) |
Chief Operating Officer (COO) |
OpGen (Group) |
Germany |
| Bachmair, Christof (Wacker Chemie 202102 Media Realtions + Information) |
Public Relations Manager / Investor Relations Manager |
Wacker (Group) |
Germany |
| Bachmann, Thomas (Eppendorf 201508–201911 CEO before Pesident of Bruker BioSpin Group + Tecan CEO LEFT 12/19) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Backhaus, Dirk (Bayer 202308 Head of Product Supply at Crop Science) |
n. a. |
Bayer (Group) |
Germany |
| Backheuer, Axel (5 Prime GmbH 201105 Managing Director) |
Managing Director |
Qiagen (Group) |
Germany |
| Bader, Augustinus (Univ Leipzig 201305 Prof for Applied Stem Cell Biology + Cell Technology) |
Professor |
University of Leipzig |
Germany |
| Bader, Manuela (Probiodrug 201711 Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Vivoryon (Group) |
Germany |
| Badiani, Kamal (Pepceuticals 202309 Managing Director) |
Managing Director |
Biosynth (since 9/22) (Group) |
United Kingdom (GB) |
| Baechler, Guido (Mainz Biomed 202111 CEO before Singulex 201305– CEO before SVP Operations before Roche Dx) |
Chief Executive Officer (CEO) |
Mainz Biomed N.V. (Nasdaq: MYNZ) |
Germany |
| Baehny, Albert M. (Lonza 202005 Board Chairman + interim CEO) |
Board member, non-executive |
Lonza (Group) |
Switzerland |
| Baerlocher, Urs (Novartis –200708) |
Board member, executive |
Novartis (Group) |
Switzerland |
| Baertschi, Gabriel (Grünenthal 201610– CEO before President AstraZeneca Japan + Managing Director AstraZeneca GmbH) |
Chief Executive Officer (CEO) |
Grünenthal (Group) |
Germany |
| Baessmann, Carsten (Bruker 201206 Head Applications Developm LC-MS at Bruker Daltonik GmbH) |
n. a. |
Bruker (Group) |
Germany |
| Baeten, Kristoff (Monkeys not Donkeys 202204 CEO + Founder) |
Chief Executive Officer (CEO) |
QbD Group (Quality by Design) (Group) |
Belgium |
| Bagaric, Marko (Berlin Cures 201802 CEO) |
n. a. |
Berlin Cures (Group) |
Switzerland |
| Bagger, Karsten (Neurosoft Bioelectronics 202103 CBO) |
Chief Business Officer (CBO) |
Neurosoft Bioelectronics (CH) |
Switzerland |
| Bahi, Khaled (Stilla Technologies 201911– CFO before Symetis + Fresenius Medical Care) |
Chief Financial Officer (CFO) |
Stilla Technologies (Group) |
France |
| Bahlmann, Ferdinand |
n. a. |
Epoplus GmbH & Co. KG |
Germany |
| Bahmani, Hamed (Dopavision 201711– Managing Director + Co-Founder) |
Managing Director |
Dopavision GmbH |
Germany |
| Bahr, Daniel (Germany (govt) 201108 Minister Health) |
Minister |
Germany (govt) |
Germany |
| Bahrs, Sönke (CyBio AG 200601 Manager Customised Solutions) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Baier, Manfred (Roche –201112 RETIRES 12/11 as head of Roche Applied Science) |
President/Director/Head Business Group/Unit/Division |
Roche (Group) |
United States (USA) |
| Baiker, Wolfgang (Adrenomed 202101–202203 CEO + Venture Partner at Wellington Partners before Boehringer Ingelheim LEFT) |
Chief Executive Officer (CEO) |
Adrenomed AG |
Germany |
| Bailey, Andrew C. (Andy) (ViruSure 201211 Managing Director, Operations) |
Managing Director |
ViruSure GmbH |
Austria |
| Bailey, Dione (Ingenuity Systems 201303 Director of Marketing) |
Sales Manager / Marketing Manager |
Qiagen (Group) |
United States (USA) |
| Baillieu, Francesca (Revent Capital 202310 Investment Manager) |
Investment Manager |
Revent Capital GmbH |
Germany |
| Baillou, Johannes (Merck (DE) 201401– Chairman of Board of Partners E Merck KG) |
Supervisory Board |
Merck (DE) (Group) |
Germany |
| Baines, Ivan (MPI Molecular Cell Biology 200802 Director) |
President/Director/Head Business Group/Unit/Division |
Max Planck Society for the Advancement of Science |
Germany |
| Baines, Julian (EKF Diagnostics 201111 CEO) |
Chief Executive Officer (CEO) |
EKF Diagnostics (Group) |
United Kingdom (GB) |
| Bairoch, Amos (Swiss Institute of Bioinformatics 2009 Professor) |
Professor |
Swiss Institute of Bioinformatics (SIB) |
Switzerland |
| Baker, Haven (Pairwise 202308 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Pairwise (Group) |
United States (USA) |
| Baker, John (Abcam 201807 SVP Portfolio + Business Development) |
Business Development Manager / Strategy Manager |
Abcam (Group) |
United Kingdom (GB) |
| Bakri, Sam (SolasCure 202108 CEO + Founder) |
Chief Executive Officer (CEO) |
SolasCure Ltd. |
United Kingdom (GB) |
| Baldoni, John (GSK 201205 SVP Platform + Technology Science) |
President/Director/Head Business Group/Unit/Division |
GSK (Group) |
United Kingdom (GB) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 4 ... 86 87 88 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
